Clinical Outcomes of Tranexamic Acid Use in Trauma Patients in Emergency and Prehospital Settings: A Systematic Review
Saudi Journal of Public Health · 15.07.2026 · 1 (3)
DOI: 10.64819/art000014 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Saudi Journal of Public Health, online erschienen am 15.07.2026. Verfasst von Najla Alaskar und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
This systematic review evaluates the clinical outcomes of tranexamic acid (TXA) administration in adult and pediatric trauma patients presenting to emergency or prehospital care, focusing on mortality, hemorrhage control, transfusion requirements, and safety.
Methods
This systematic review was conducted in accordance with PRISMA 2020 guidelines. PubMed/MEDLINE, Embase, Cochrane CENTRAL, and Scopus were searched from inception to the final search date, alongside trial registries and reference lists. Evidence from large multinational randomized controlled trials (RCTs), prehospital trials, and smaller single-center RCTs was synthesized narratively.
Results
TXA significantly reduces all-cause and bleeding-related mortality when administered early, particularly within 3 hours and ideally within 1 hour of injury. Benefits are most pronounced in patients with active hemorrhage. While some trials showed reduced blood loss and transfusion needs, large multicenter studies did not consistently demonstrate differences in transfusion rates. TXA was not associated with an increased risk of thromboembolic events. In traumatic brain injury, early TXA may reduce head injury-related mortality in mild to moderate cases, but does not significantly improve long-term functional outcomes.
Conclusion
TXA is an effective and safe intervention for reducing early mortality in bleeding trauma patients when administered promptly after injury. From a public health perspective, its low cost, ease of administration, and suitability for emergency and prehospital protocols make TXA particularly valuable for strengthening trauma systems, especially where access to definitive hemorrhage control may be delayed. Timing remains critical, with maximal benefit achieved within the first hour.
Zitieren
APA
Alaskar, N., Alharbi, M., Ghabban, R., & Alharbi, O. (2026). Clinical Outcomes of Tranexamic Acid Use in Trauma Patients in Emergency and Prehospital Settings: A Systematic Review. Saudi Journal of Public Health, 1(3). https://doi.org/10.64819/art000014
Vancouver
Alaskar N, Alharbi M, Ghabban R, Alharbi O. Clinical Outcomes of Tranexamic Acid Use in Trauma Patients in Emergency and Prehospital Settings: A Systematic Review. Saudi Journal of Public Health. 2026;1(3). doi:10.64819/art000014
BibTeX
@article{Alaskar2026,
author = {Alaskar, Najla and Alharbi, Mohammed and Ghabban, Raghad and Alharbi, Omar},
title = {Clinical Outcomes of Tranexamic Acid Use in Trauma Patients in Emergency and Prehospital Settings: A Systematic Review},
journal = {Saudi Journal of Public Health},
year = {2026},
volume = {1},
number = {3},
doi = {10.64819/art000014}
}
EUVIMED